Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine.

Hirata Y, Furuhashi K, Ishii H, Li HW, Pinho S, Ding L, Robson SC, Frenette PS, Fujisaki J.

Cell Stem Cell. 2018 Mar 1;22(3):445-453.e5. doi: 10.1016/j.stem.2018.01.017. Epub 2018 Feb 15.

PMID:
29456159
2.

Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals.

Sawai CM, Babovic S, Upadhaya S, Knapp DJHF, Lavin Y, Lau CM, Goloborodko A, Feng J, Fujisaki J, Ding L, Mirny LA, Merad M, Eaves CJ, Reizis B.

Immunity. 2016 Sep 20;45(3):597-609. doi: 10.1016/j.immuni.2016.08.007. Epub 2016 Aug 30.

3.

MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice.

Hirata Y, Li HW, Takahashi K, Ishii H, Sykes M, Fujisaki J.

PLoS One. 2015 Nov 6;10(11):e0141785. doi: 10.1371/journal.pone.0141785. eCollection 2015.

4.

Tracking single cells in live animals using a photoconvertible near-infrared cell membrane label.

Carlson AL, Fujisaki J, Wu J, Runnels JM, Turcotte R, Spencer JA, Celso CL, Scadden DT, Strom TB, Lin CP.

PLoS One. 2013 Aug 26;8(8):e69257. doi: 10.1371/journal.pone.0069257. eCollection 2013. Erratum in: PLoS One. 2013;8(11). doi:10.1371/annotation/c05446df-ee55-4072-940c-543adff42086. Spencer, Joel A [added].

5.

In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.

Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey ME, Poveromo LP, Cowley GS, Kharas MG, Labelle M, Shterental S, Fujisaki J, Silberstein L, Alexe G, Al-Hajj MA, Shelton CA, Armstrong SA, Root DE, Scadden DT, Hynes RO, Mukherjee S, Stegmaier K, Jordan CT, Ebert BL.

Cancer Cell. 2013 Jul 8;24(1):45-58. doi: 10.1016/j.ccr.2013.05.004. Epub 2013 Jun 13.

6.

Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, Lin CP, Kronenberg HM, Scadden DT.

Cell Stem Cell. 2012 Mar 2;10(3):259-72. doi: 10.1016/j.stem.2012.02.003.

7.

In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche.

Fujisaki J, Wu J, Carlson AL, Silberstein L, Putheti P, Larocca R, Gao W, Saito TI, Lo Celso C, Tsuyuzaki H, Sato T, Côté D, Sykes M, Strom TB, Scadden DT, Lin CP.

Nature. 2011 Jun 8;474(7350):216-9. doi: 10.1038/nature10160.

8.

Persistence of donor-derived protein in host myeloid cells after induced rejection of engrafted allogeneic bone marrow cells.

Saito TI, Fujisaki J, Carlson AL, Lin CP, Sykes M.

Exp Hematol. 2010 Apr;38(4):333-9. doi: 10.1016/j.exphem.2010.02.003. Epub 2010 Feb 16.

9.

Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche.

Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, Côté D, Rowe DW, Lin CP, Scadden DT.

Nature. 2009 Jan 1;457(7225):92-6. doi: 10.1038/nature07434. Epub 2008 Dec 3.

10.

Primary cardiac lymphoma presenting clinically as restrictive cardiomyopathy.

Fujisaki J, Tanaka T, Kato J, Saito T, Yano K, Shimizu Y, Sada T, Kitazume K, Fujita A, Kira Y.

Circ J. 2005 Feb;69(2):249-52.

Supplemental Content

Loading ...
Support Center